ReviewFrontiers in immunology2026
Advances in the role of specialized pro-resolving mediators in periodontitis.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Periodontitis is a chronic inflammatory disease driven by dysregulated host-microbial interactions and failure of endogenous inflammation resolution, leading to progressive destruction of periodontal tissues. Increasing evidence indicates that inflammation resolution is an active, tightly regulated biological program governed by specialized pro-resolving mediators (SPMs), including resolvins, lipoxins, protectins, and maresins. Unlike conventional anti-inflammatory agents, SPMs do not suppress host defense but instead actively terminate inflammation and promote tissue regeneration. Mechanistically, SPMs signal through specific G protein-coupled receptors to inhibit neutrophil recruitment, enhance macrophage efferocytosis, and promote M2 macrophage polarization. They also suppress pro-inflammatory signaling pathways such as NF-κB and NLRP3 inflammasome activation, while restoring immune balance by modulating Treg/Th17 responses. Importantly, SPMs regulate periodontal bone homeostasis by correcting the RANKL/OPG imbalance and supporting osteogenic differentiation of periodontal ligament cells. This review summarizes the biosynthesis, receptor-mediated signaling, and functional roles of SPMs in periodontitis, highlighting their may connect inflammation resolution and tissue regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.